VIR Competitors & Alternatives
Compare Vir Biotechnology Inc with similar stocks in the same industry
Biotechnology
VIR
Main Stock$10.51
Tradestie Score
47
Market Cap
$791.82M
Revenue Growth
195.8%
Analyst Upside
+99.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$6.41
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$65.56
|
$1.92B | - | 58 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$41.69
|
$1.90B | 26.3 | 46 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$27.72
|
$1.84B | - | 54 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$31.07
|
$1.81B | - | 39 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.76
|
$1.78B | - | 58 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.47
|
$1.78B | - | 47 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$138.32
|
$1.77B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$22.42
|
$1.74B | - | 35 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$28.93
|
$1.68B | - | 66 | Compare |
More VIR Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry